Association Between Matrix Metalloproteinase-9 Gene Polymorphism and Susceptibility to Primary Open Angle Glaucoma Patients in Sohag University Hospital

NCT07119905 — Not yet recruiting, 80 participants, Sohag University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT07119905
StatusNot yet recruiting
Study typeObservational
Enrollment80 (Estimated)
SponsorSohag University (Other)
ConditionsPrimary Open Angle Glaucoma (POAG)
Interventionsgenotyping assay by polymerase chain reaction (Genetic)
Datesstart 2026-06-01 (estimated), primary completion 2027-01-01 (estimated), completion 2027-02-01 (estimated), first posted 2025-08-13, last updated 2025-08-13
Locations1 site in Egypt

Related Papers Related Patents Related Grants Related Experts
All trials for Primary Open Angle Glaucoma (POAG) All trials of genotyping assay by polymerase chain reaction

-Summary

The goal of this observational study is to investigate the potential association between MMP-9 gene polymorphism and susceptibility to Primary Open Angle Glaucoma development in Egyptian patients The main question it aims to

Expand all sections  ·  Collapse all

+Detailed description

Glaucoma is the second most common cause of blindness worldwide. Glaucoma is a progressive optic neuropathy, characterized by a specific loss of retinal nerve fibres and ganglion cells, gradual decrease of the visual field, and vertical elongation of optic disc cupping. Glaucoma causes a slow loss of vision in the centre of the field of view as well as in the periphery. This results in delays in the diagnosis and treatment, and it is likely that the glaucoma may not be diagnosed until the disease has progressed to a moderate or severe level, at which point significant vision loss will have already taken place

POAG is the most common type of glaucoma that is characterized by specific glaucomatous retinal, optic nerve, and clinical findings without a clear secondary cause.

POAG is a progressive optic neuropathy characterized by loss of ganglion cells and deterioration of the visual field in eyes with gonioscopically open angles, either with or without increased intraocular pressure (IOP).

Matrix Metalloproteinase-9 gene Matrix metalloproteinases (MMPs) are a kind of calcium-zinc ion-dependent proteolytic enzyme involved in a variety of cellular processes. MMPs are well known for their ability to degrade the extracellular matrix (ECM) and are involved in several intracellular mechanisms from cell differentiation, proliferation, and angiogenesis to apoptosis.

The MMP genes were suggested to play an important role in the development of various glaucoma types, MMPs are important regulators of the aqueous humor outflow from the eye anterior chamber and therefore significantly affect intraocular pressure. Patients with diagnosed POAG have an altered MMPs level in the aqueous humor.

Several studies have been conducted to analyze polymorphic variants of the MMP for their possible contribution to POAG, Several loci of the MMP genes (rs3918242, rs3918249, rs17576 matrix metalloproteinase-9 were associated with POAG.

+Arms and interventions

ArmTypeInterventionsDescription
Control GroupGenetic: genotyping assay by polymerase chain reactionNormal healthy volunteers aged > 30 years
Experimental GroupGenetic: genotyping assay by polymerase chain reactionPatients aged >30 years and diagnosed with Primary Open Angle Glaucoma
  • genotyping assay by polymerase chain reaction (Genetic): Blood sample will be obtained from all participants by withdrawing 3 mL of blood via venipuncture in ethylenediaminetetraacetic acid tube. Thereafter, DNA extraction will be obtained after centrifugation to be used for genotyping assay of MMP-9 gene with polymerase chain reaction

+Outcome measures

Primary outcomes

  • Matrix metalloproteinase-9 gene polymorphism [14 months]: Matrix metalloproteinase-9 gene polymorphism by polymerase chain reaction

+Eligibility

Sex: All, ages: 30 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Men and women older than 30 years
* Primary open angle glaucoma as evidenced from characteristic visual field loss and optic disc cupping (POAG group)
* Healthy subjects matched by age, sex and ethnicity to the POAG patients group (control group)

Exclusion Criteria:

* Exfoliation glaucoma, pigmentary glaucoma
* History of acute angle closure

+Locations (1)

FacilityCityCountryStatus
Sohag University HosipitalSohag, Sohag GovernorateEgypt

+Publications

  • Grzybowski A, Och M, Kanclerz P, Leffler C, Moraes CG. Primary Open Angle Glaucoma and Vascular Risk Factors: A Review of Population Based Studies from 1990 to 2019. J Clin Med. 2020 Mar 11;9(3):761. doi: 10.3390/jcm9030761. PMID 32168880
  • Liu Y, Allingham RR. Major review: Molecular genetics of primary open-angle glaucoma. Exp Eye Res. 2017 Jul;160:62-84. doi: 10.1016/j.exer.2017.05.002. Epub 2017 May 10. PMID 28499933
  • Zhao F, Fan Z, Huang X. Role of matrix metalloproteinase-9 gene polymorphisms in glaucoma: A hospital-based study in Chinese patients. J Clin Lab Anal. 2020 Mar;34(3):e23105. doi: 10.1002/jcla.23105. Epub 2019 Nov 12. PMID 31713905